Transgenomic (TBIO) Reports Q1 Loss Per Share of $0.36
Tweet
Share
E-mailGet Alerts TBIO Hot Sheet
Price: $3.23 --0%
Financial Fact:
Selling, general and administrative: 1.25M
Today's EPS Names:
SVBT, ZEO, OTLK, More
Financial Fact:
Selling, general and administrative: 1.25M
Today's EPS Names:
SVBT, ZEO, OTLK, More
Join SI Premium – FREE
Transgenomic (NASDAQ: TBIO) reported Q1 EPS of ($0.36), versus ($0.60) reported last year. Revenue for the quarter came in at $6.51 million, versus $62.5 million reported last year.
For earnings history and earnings-related data on Transgenomic (TBIO) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Tesla plans 'flying' Roadster stunt at SpaceX Texas site as early as August
- Hydrofarm Holdings Group, Inc. (HYFM) Misses Q2 EPS by 134c
- Tvardi Therapeutics (TVRD) Tops Q2 EPS by 1c
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
